Showing 8991-9000 of 21418 results for "".
Improving CKD Patient Outcomes with SGLT2 Inhibitors
https://reachmd.com/programs/clinicians-roundtable/improving-ckd-patient-outcomes-with-sglt2-inhibitors/17943/How are SGLT2 inhibitors helping patients with CKD? Tune in.Potential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
https://reachmd.com/programs/medical-industry-feature/potential-for-early-intervention-in-1l-hrher2-advanced-breast-cancer/39209/To help patients with HR+/HER2- advanced breast cancer have the best chance of extending the benefit of first-line aromatase inhibitor plus CDK4/6 inhibitor regimens, it may be critical to detect emerging endocrine resistance as early as possible.1-3 As exposure to aromatase inhibitors increases, EJAMA: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies
https://reachmd.com/programs/Audioabstracts/jama-noninvasive-prenatal-testing-and-incidental-detection-occult-maternal-malignancies/7628/Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; JamInnovations in Less-Invasive Epilepsy Surgery
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/innovations-in-less-invasive-epilepsy-surgery/39963/Recent developments in epilepsy surgery underscore a growing trend toward reduced invasiveness and expanded clinical indications.Serum and Urine Immunofixation Electrophoresis in ATTR-CM: Exclusion Before Confirmation
https://reachmd.com/programs/spotlight-attr-cm/serum-and-urine-immunofixation-electrophoresis-in-attr-cm-exclusion-before-confirmation/67157/Assessing and Interpreting pCR in Perioperative NSCLC
https://reachmd.com/programs/project-oncology/perioperative-nsclc-pcr-assessment/49112/Pathologic complete response (pCR) has emerged as a key surrogate endpoint in perioperative non-small cell lung cancer (NSCLC), offering valuable insight into treatment efficacy and long-term outcomes. Joining Dr. Steve Jackson to discuss how pCR is defined and assessed following neoadjuvant therapySubcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
https://reachmd.com/programs/project-oncology/subcutaneous-isatuximab-matches-iv-in-multiple-myeloma-insights-from-iraklia/36403/The phase 3 IRAKLIA trial evaluated the subcutaneous delivery of isatuximab via an on-body injector plus pomalidomide and dexamethasone versus the standard IV regimen in patients with relapsed/refractory multiple myeloma. Results showed comparable overall response rates, steady-state trough concentrThe Endocrine Society's 2010 Annual Meeting
https://reachmd.com/programs/conference-coverage/the-endocrine-societys-2010-annual-meeting/5743/Hear highlights from research on the management of obesity, endocrine disorders, diabetes, menopause, and thyroid cancer presented at the Endocrine Society's 92nd Annual Meeting and Expo. The meeting took place June 19 to 22, 2010, in San Diego.A Look at Immunizations Through Time
https://reachmd.com/programs/covid-19-frontlines/a-look-at-immunizations-through-time/11580/Immunization techniques have been evolving since the 1100s. Could the techniques of the past help us in our current hunt for a COVID-19 vaccine?10 Legal and Compliance Issues that Should be Top of Mind for Aesthetic Practices
https://reachmd.com/ma-issues-index/may-jun-2026-issue/10-legal-and-compliance-issues-that-should-be-top-of-mind-for-aesthetic-practices/59176/Avoid penalties and liabilities by understanding and complying with all relevant regulations.